RxDoctor Payments Data

David Greenberg, DPM

Foot & Ankle Surgery · Riverside, RINPI 1801975545

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,025 of the $6,035 with a category attached, or 83.3%. 14 manufacturers reported payments, led by Biotissue Holdings Inc. at 55.8% of the total. Reporting peaked in 2022 at $3,006 and has fallen 70.5% since, to $888 in 2025.

$6,035in general payments, 2019–2025

Across 123 payments — averaging $49.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotissue Holdings Inc.$3K
  • Smith+Nephew$971
  • Stryker$351
  • Treace Medical Concepts, Inc.$325
  • Orthofix Medical, Inc.$311
  • Zimmer Biomet$164
  • plus $546 from 8 others

What the payments were for

  • Travel & lodging$1,01017%
  • Food & beverage$5,02583%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,035 in reported general payments places this provider in the 70th percentile of 58 foot & ankle surgery providers in Rhode Island.

See all foot & ankle surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$242,785
Medicare patients
796
Services billed
3,693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Terbinafine Hcl102$1,124
Ketoconazole54$1,020
Methylprednisolone95$729
Ammonium Lactate46$677
Gabapentin47$547
Ibuprofen63$339
Silver Sulfadiazine37$317
Cephalexin44$266
Meloxicam43$160
Duloxetine Hcl13$124
Triamcinolone Acetonide12$112
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$94
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$94
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$87

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Riverside

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →